AI & DIGITAL ONCOLOGY
ESMO awards its first fellowship to support digital and computational pathology
The recipient, Balazs Acs from Karolinska Institutet, will conduct a two-year project to transform the manual aspects of breast cancer pathology into quantitative ones
A toolkit to address disparities in digitally enabled oncology trials
An initiative fosters inclusive research by improving patient access and participation in cancer research
AI and remote monitoring are shaping a new patient journey in oncology
Real world experience suggests that the integration of digital tools into cancer care may close current gaps in patient outcomes reporting
LATEST NEWS
The updated ESMO-MCBS captures the evolving treatment landscape and patient priorities
The ESMO-Magnitude of Clinical Benefit Scale has been enhanced to address critical aspects of modern oncology trials, such as novel study designs, quality of life and long-term survival benefits
Patient-reported outcomes in dose-finding show value in oncology trial inclusion, but shared standards are needed
Findings from studies show that patient-centred evidence can inform decisions in early-phase cancer research
Subcutaneous pembrolizumab demonstrates noninferiority to intravenous administration
Phase III data in metastatic NSCLC support an alternative route of administering immunotherapy, which may have an impact on patients’ preferences and cancer care costs
OPINIONS
Integrating multiomic spatial profiling and ctDNA for a deeper understanding of cancer complexity
Umberto Malapelle
Next-generation CAR-T cells are in the pipeline
Philippe Cassier
Target-led treatments for lung cancer – are they moving to the next level?
Tony SK Mok
Technology integration and access to eligible patients underpin the growth of early-phase trials in Asia Pacific
Lilian L. Siu
ctDNA and RNA-based tests are expanding colorectal cancer screening options
Frank A. Sinicrope
OPINIONS
Integrating multiomic spatial profiling and ctDNA for a deeper understanding of cancer complexity
Umberto Malapelle
Next-generation CAR-T cells are in the pipeline
Philippe Cassier
Target-led treatments for lung cancer – are they moving to the next level?
Tony SK Mok
Technology integration and access to eligible patients underpin the growth of early-phase trials in Asia Pacific
Lilian L. Siu
ctDNA and RNA-based tests are expanding colorectal cancer screening options
Frank A. Sinicrope